Prenetics announces a manifesto detailing its rapid growth strategy and Bitcoin treasury approach, projecting significant future revenues.
Quiver AI Summary
Prenetics Global Limited announced the release of a comprehensive manifesto by CEO Danny Yeung, outlining the company's innovative strategy combining rapid growth in the health supplement industry and Bitcoin treasury management. The company's IM8 brand achieved a record $100 million annual recurring revenue in just 11 months, making it the fastest growing supplement brand ever, and is projected to reach $180-$200 million in revenue by 2026. Prenetics, co-founded with David Beckham and supported by tennis champion Aryna Sabalenka, also manages a Bitcoin treasury, currently holding 277 BTC and acquiring one Bitcoin daily. This dual-engine strategy of healthcare growth coupled with Bitcoin investments aims to create long-term value and financial resilience, fostering a cycle of growth that surpasses traditional business models.
Potential Positives
- IM8 achieved $100 million in annual recurring revenue within just 11 months of launch, marking the fastest growth in supplement industry history.
- The company projects impressive revenue growth of $180 to $200 million for FY 2026, indicating strong future financial performance.
- Prenetics is pioneering the integration of healthcare growth with Bitcoin treasury management, establishing itself as the first consumer health company to adopt a Bitcoin Treasury strategy.
- The manifesto provides unprecedented transparency into the company’s strategic vision, enhancing investor trust and engagement.
Potential Negatives
- The company's reliance on a Bitcoin treasury strategy introduces significant risk due to the inherent volatility of Bitcoin, which could negatively impact financial stability.
- Forward-looking statements indicate uncertainty about the company's ability to meet its financial projections and manage growth effectively, raising concerns about future performance.
- The competitive nature of the consumer health market poses challenges, which could hinder the company's ability to sustain its growth momentum.
FAQ
What is the main focus of Prenetics' new manifesto?
The manifesto outlines Prenetics' strategic vision of combining healthcare growth with Bitcoin treasury management for long-term value creation.
How quickly did IM8 achieve $100 million in revenue?
IM8 reached $100 million in annual recurring revenue within just 11 months of its launch, marking the fastest growth in the supplement industry.
What are Prenetics' revenue projections for FY 2026?
Prenetics projects revenue between $180 million and $200 million for the fiscal year 2026.
How does Prenetics manage its Bitcoin treasury?
Prenetics employs a disciplined strategy of daily accumulating 1 Bitcoin, totaling 277 BTC as of October 29, 2025.
Where can I access Prenetics' manifesto?
The manifesto is available in various formats at https://www.prenetics.com/manifesto for different audience preferences.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$PRE Hedge Fund Activity
We have seen 2 institutional investors add shares of $PRE stock to their portfolio, and 4 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 24,822 shares (+inf%) to their portfolio in Q2 2025, for an estimated $211,359
- UBS GROUP AG removed 20,605 shares (-75.1%) from their portfolio in Q2 2025, for an estimated $175,451
- QUINN OPPORTUNITY PARTNERS LLC removed 12,339 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $105,066
- NOMURA HOLDINGS INC removed 11,703 shares (-3.5%) from their portfolio in Q2 2025, for an estimated $99,651
- MORGAN STANLEY added 6,800 shares (+320.2%) to their portfolio in Q2 2025, for an estimated $57,902
- SBI SECURITIES CO., LTD. removed 56 shares (-98.2%) from their portfolio in Q2 2025, for an estimated $476
- STEVENS CAPITAL PARTNERS added 0 shares (+0.0%) to their portfolio in Q3 2025, for an estimated $0
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Comprehensive Document Reveals Strategic Vision Behind Company's Unprecedented Growth and Bitcoin Treasury Strategy
IM8, the Fastest-Growing Supplement Brand in Industry History, Reaching Reaches $100M ARR in 11 Months Since Launch
IM Projects $180-$200 Million in FY 2026 Revenue
CHARLOTTE, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE (“Prenetics” or the “Company”), a leading health sciences company, today announced the publication of a comprehensive manifesto authored by CEO and Co-Founder Danny Yeung, titled "The Dual-Engine Revolution: A Manifesto for Building the Future of Health + Wealth." The document provides unprecedented transparency into the Founder led Company's strategic thinking, revealing the entrepreneurial journey and pattern recognition that led to Prenetics' groundbreaking approach of combining explosive healthcare growth with sophisticated Bitcoin treasury management.
The manifesto is available in multiple formats to suit different audiences and preferences, including a comprehensive 32-page version, an executive summary, a video presentation, and an audio narration. It outlines how integrating healthcare growth with Bitcoin treasury management can create meaningful, long-term value:
Healthcare Engine (IM8): The brand achieved $100 million in annual recurring revenue within 11 months of launch: the fastest growth in supplement industry history. Co-founded with David Beckham and backed by World #1 tennis champion Aryna Sabalenka, IM8 is projecting $180 to $200 million in revenue for 2026.
Bitcoin Treasury Engine: As of today, the Company holds 277 BTC and is consistently adding to its position through a disciplined daily accumulation strategy of 1 BTC, Prenetics is building what Yeung calls a "fortress of value" that provides financial resilience and appreciation potential independent of traditional financial systems.
The Synergy: IM8's explosive growth generates substantial cash flows that enable sophisticated Bitcoin treasury management, while the Bitcoin treasury provides financial appreciation that can accelerate healthcare expansion—creating a virtuous cycle that single-engine companies cannot match.
Access to the manifesto in all formats at: https://www.prenetics.com/manifesto
For comprehensive financial information and investor materials, please visit: https://ir.prenetics.com/
For real-time access to the Company’s Bitcoin holdings, please visit https://prenetics.com/btc
Investor Relations Contact:
[email protected]
[email protected]
Angela Cheung
Investor Relations / Corporate Finance
[email protected]
About Prenetics
Prenetics (NASDAQ: PRE) is a leading health sciences company redefining the future of health and longevity through IM8 — its flagship consumer brand co-founded with David Beckham and championed by World No. 1 and four-time Grand Slam winner Aryna Sabalenka — now the fastest-growing supplement brand globally, reaching $100 million in annual recurring revenue within just 11 months of launch — the fastest growth ever recorded in the global history of the supplements industry, even outpacing today’s leading AI startups.
As the first consumer health company to establish a Bitcoin Treasury, Prenetics continues to pioneer at the intersection of health innovation and digital assets — purchasing 1 Bitcoin per day, now totaling 277 BTC as of October 29, 2025.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” and similar statements. Prenetics may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors, or employees to third parties. Statements that are not historical facts, including statements about Prenetics’ beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s ability to meet all of the terms and conditions of the offering and complete the offering, the Company’s ability to execute its new Bitcoin treasury strategy; the volatility of Bitcoin; the Company’s ability to manage its growth and expansion; the company’s ability to compete in the highly competitive consumer health market; and other risks and uncertainties. Further information regarding these and other risks is included in Prenetics’ filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and Prenetics does not undertake any obligation to update any forward-looking statement, except as required under applicable law.